| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Accounting Officer | SVP, Finance &CAO | SVP, Finance &CAO +1 more
1 company
Utter Christine Marie is a SVP, Chief Accounting Officer at PTCT. Recent filings cover 0 purchases and 80 sales. Those positions are worth an estimated $5.3M at current prices.
Our model assigns Utter Christine Marie a middling insider score of 58/100, based on 22 past trades. Over a 12-month horizon, 36.8% of those trades were profitable, with an average 12-month return of -11.8%.
Utter Christine Marie's largest disclosed position is in PTCT as SVP, Chief Accounting Officer, worth about $5.3M. The recent filings there lean toward selling, a net 212,611 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 13, 2021 | PTCT Ptc Therapeutics, Inc. | SVP, Finance &CAO | Sale+OE | 3,947 | $66.57 | $262,751.79 | -18.4% | |
| Jan 5, 2021 | PTCT Ptc Therapeutics, Inc. | SVP, Finance &CAO | Sell | 316 | $62.37 | $19,708.92 | -3.2% | |
| Nov 4, 2020 | PTCT Ptc Therapeutics, Inc. | SVP, Finance &CAO | Sale+OE | 31,758 | $60.06 | $1,907,404.40 | -76.9% | |
| Oct 6, 2020 | PTCT Ptc Therapeutics, Inc. | SVP, Finance &CAO | Sale+OE | 3,287 | $49.75 | $163,518.66 | -25.6% | |
| Jul 6, 2020 | PTCT Ptc Therapeutics, Inc. | SVP, Finance &CAO | Sale+OE | 3,288 | $53.70 | $176,564.24 | -25.6% | |
| Apr 17, 2020 | PTCT Ptc Therapeutics, Inc. | SVP, Finance &CAO | Sale+OE | 2,145 | $50.00 | $107,250.00 | -18.7% | |
| Apr 3, 2020 | PTCT Ptc Therapeutics, Inc. | SVP, Finance &CAO | Sale+OE | 787 | $44.31 | $34,871.97 | -7.8% | |
| Jan 7, 2020 | PTCT Ptc Therapeutics, Inc. | SVP, Finance &CAO | Sale+OE | 14,110 | $49.97 | $705,072.98 | -73.0% | |
| Jan 3, 2020 | PTCT Ptc Therapeutics, Inc. | SVP, Finance &CAO | Sale+OE | 3,150 | $47.77 | $150,478.42 | -36.1% | |
| Jul 1, 2019 | PTCT Ptc Therapeutics, Inc. | SVP, Finance &CAO | Sale+OE | 14,059 | $45.14 | $634,602.58 | -74.0% |